Impact of the Type of Interface in Neuromuscular Patients Treated With Nocturnal Noninvasive Ventilation

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 28, 2018

Primary Completion Date

June 28, 2018

Study Completion Date

June 26, 2019

Conditions
Neuromuscular DiseasesAlveolar Hypoventilation
Interventions
DEVICE

Switch of nocturnal NIV interface

"1. test the alternative interfaces (either a nasal mask for the patient used to oronasal mask or inversely an oronasal mask if the usual mask is nasal) during a one-hour diurnal NIV session. SpO2 (polygraphy), PtcCO2 will be monitored continuously during this diurnal session. Patients will use their usual NIV device prescribed at home. NIV settings will be adapted if needed.~2. Interface switch~3. unattended nocturnal polygraphy under NIV (cf details below) will be performed at home with SomnoHolter® (Nomics, Liege, Belgium), synchronized with transcutaneous partial pressure in CO2 (PtcCO2) monitoring by SenTec V-Sign™ System.~The PtcCO2 device will be calibrated before and at the end of each night to allow drift correction."

Trial Locations (1)

38000

Grenoble-Alpes University hospital, Grenoble

All Listed Sponsors
collaborator

Association Française contre les Myopathies (AFM), Paris

OTHER

collaborator

Hôpital Raymond Poincaré

OTHER

lead

University Hospital, Grenoble

OTHER

NCT03458507 - Impact of the Type of Interface in Neuromuscular Patients Treated With Nocturnal Noninvasive Ventilation | Biotech Hunter | Biotech Hunter